These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 36905810

  • 1. Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice.
    Costa G, Serra M, Maccioni R, Casu MA, Kasture SB, Acquas E, Morelli M.
    Biomed Pharmacother; 2023 May; 161():114475. PubMed ID: 36905810
    [Abstract] [Full Text] [Related]

  • 2. In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice.
    Costa G, Spulber S, Paci E, Casu MA, Ceccatelli S, Simola N, Morelli M.
    Neurotoxicology; 2021 Mar; 83():1-13. PubMed ID: 33338551
    [Abstract] [Full Text] [Related]

  • 3. MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice.
    Costa G, Frau L, Wardas J, Pinna A, Plumitallo A, Morelli M.
    Mov Disord; 2013 Dec; 28(14):1957-65. PubMed ID: 24108425
    [Abstract] [Full Text] [Related]

  • 4. Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent.
    Frau L, Costa G, Porceddu PF, Khairnar A, Castelli MP, Ennas MG, Madeddu C, Wardas J, Morelli M.
    J Neurochem; 2016 Jan; 136(1):148-62. PubMed ID: 26442661
    [Abstract] [Full Text] [Related]

  • 5. Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain.
    Frau L, Simola N, Porceddu PF, Morelli M.
    Neurotoxicology; 2016 Sep; 56():127-138. PubMed ID: 27451954
    [Abstract] [Full Text] [Related]

  • 6. Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration.
    Porceddu PF, Ishola IO, Contu L, Morelli M.
    Neurotox Res; 2016 Jul; 30(1):101-9. PubMed ID: 27251371
    [Abstract] [Full Text] [Related]

  • 7. Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('ecstasy') in mouse brain.
    Khairnar A, Plumitallo A, Frau L, Schintu N, Morelli M.
    Neurotox Res; 2010 May; 17(4):435-9. PubMed ID: 19882200
    [Abstract] [Full Text] [Related]

  • 8. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine.
    Miller DB, O'Callaghan JP.
    Mol Neurobiol; 1995 May; 11(1-3):177-92. PubMed ID: 8561961
    [Abstract] [Full Text] [Related]

  • 9. The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.
    Miner NB, O'Callaghan JP, Phillips TJ, Janowsky A.
    Neurotoxicol Teratol; 2017 May; 61():74-81. PubMed ID: 28212938
    [Abstract] [Full Text] [Related]

  • 10. THC Prevents MDMA Neurotoxicity in Mice.
    Touriño C, Zimmer A, Valverde O.
    PLoS One; 2010 Feb 10; 5(2):e9143. PubMed ID: 20174577
    [Abstract] [Full Text] [Related]

  • 11. MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex.
    Costa G, Simola N, Morelli M.
    Psychopharmacology (Berl); 2014 Oct 10; 231(20):4007-18. PubMed ID: 24687411
    [Abstract] [Full Text] [Related]

  • 12. Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity.
    Costa G, Morelli M, Simola N.
    Neurotox Res; 2018 Nov 10; 34(4):763-768. PubMed ID: 29629511
    [Abstract] [Full Text] [Related]

  • 13. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice.
    Granado N, O'Shea E, Bove J, Vila M, Colado MI, Moratalla R.
    J Neurochem; 2008 Nov 10; 107(4):1102-12. PubMed ID: 18823368
    [Abstract] [Full Text] [Related]

  • 14. Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.
    Shen EY, Ali SF, Meyer JS.
    Neuropharmacology; 2011 Dec 10; 61(8):1183-92. PubMed ID: 21763331
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N, Ares-Santos S, Oliva I, O'Shea E, Martin ED, Colado MI, Moratalla R.
    Neurobiol Dis; 2011 Jun 10; 42(3):391-403. PubMed ID: 21303698
    [Abstract] [Full Text] [Related]

  • 16. Concurrent Inhibition of Vesicular Monoamine Transporter 2 Does Not Protect Against 3,4-Methylenedioxymethamphetamine (Ecstasy) Induced Neurotoxicity.
    Cholanians AB, Phan AV, Lau SS, Monks TJ.
    Toxicol Sci; 2019 Jul 01; 170(1):157-166. PubMed ID: 30923810
    [Abstract] [Full Text] [Related]

  • 17. Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age.
    Costa G, Porceddu PF, Serra M, Casu MA, Schiano V, Napolitano F, Pinna A, Usiello A, Morelli M.
    Int J Mol Sci; 2019 Mar 28; 20(7):. PubMed ID: 30925704
    [Abstract] [Full Text] [Related]

  • 18. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
    Pubill D, Canudas AM, Pallàs M, Camins A, Camarasa J, Escubedo E.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 May 28; 367(5):490-9. PubMed ID: 12684743
    [Abstract] [Full Text] [Related]

  • 19. Influence of chronic caffeine on MDMA-induced behavioral and neuroinflammatory response in mice.
    Ruiz-Medina J, Pinto-Xavier A, Rodríguez-Arias M, Miñarro J, Valverde O.
    Psychopharmacology (Berl); 2013 Mar 28; 226(2):433-44. PubMed ID: 23187789
    [Abstract] [Full Text] [Related]

  • 20. Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.
    Mueller M, Maldonado-Adrian C, Yuan J, McCann UD, Ricaurte GA.
    J Pharmacol Exp Ther; 2013 Feb 28; 344(2):479-88. PubMed ID: 23209329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.